REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$64.20
arrow_upward
+1.23%(+0.78) 1D
Oct 14, 10:58:00 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$64.20
High
R$64.20
Low
R$64.20
Mkt. cap
78.99B
Avg. vol.
781.00
Volume
8.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
Open
R$64.20
High
R$64.20
Low
R$64.20
Mkt. cap
78.99B
Avg. vol.
781.00
Volume
8.00
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
ad-hoc-news.de
·
2 hours ago
Regeneron reports Pasatru data and Regeneron stock trades at EUR 677.30
Investor's Business Daily
·
2 hours ago
Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
ad-hoc-news.de
·
1 day ago
RBC raises target for Regeneron stock to USD 810.00
The Globe and Mail
·
1 day ago
Citi Keeps Their Hold Rating on Regeneron (REGN)
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com